Stem cell therapy is a new option to intervene in neurological damage after cerebral hemorrhage. In recent years, alternative therapies (exogenous stem cell transplantation) have become a research hotspot for repairing central nervous system damage, but they have not yet been widely used in clinical practice. The results of clinical studies have shown that stem cell therapy can inhibit the damage of peroxynitrite to the blood-brain barrier in all patients and protect the integrity of the blood-brain barrier, promoting the repair of neural tissue. It can also reduce the severity of cerebral edema after cerebral hemorrhage and improve neurological function, suggesting that various trophic factors secreted by MSCs play an important role in neuronal repair. It is certain that stem cell transplantation is a potential treatment for cerebral hemorrhage. However, stem cell-related therapies are not yet mature enough to require further clinical trials and research, and currently carry certain risks, such as the optimal timing of therapeutic intervention of stem cells in the pathogenesis, the quantity needed, and the source. The treatment of cerebral hemorrhage hemiplegia should also be standardized under the guidance of professional doctors to avoid delaying the condition.